PARP1 and atrial fibrillation: Restoring NAD+ levels presents another strategy for reversing proteostasis disruption, as inhibiting PARP1 preserves NAD+ levels crucial for sirtuin function, with selective PARP1 inhibitors like ABT-888 showing potential benefits in both AF and PH [27,152].